<!DOCTYPE html>
<html lang="en">
  <head>
	<meta charset="utf-8" />
	<meta http-equiv="X-UA-Compatible" content="IE=edge" />
	<meta id="viewport" name="viewport" content="width=device-width, initial-scale=1" />

	<title>Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation | ScienceDaily</title>

	<meta name="description" content="CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy's molecular target improved response." id="metasummary" />
	<meta name="keywords" content="Lymphoma; Leukemia; Diseases and Conditions; Personalized Medicine; Immune System; Stem Cells; Cancer; Gene Therapy" id="metakeywords" />

	<meta name="last-modified" content="Thu, 11 Jul 2024 02:32:01 GMT" />
	<meta name="expires" content="Thu, 11 Jul 2024 03:32:01 GMT" />

	<meta property="og:title" id="og_title" content="Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation" />
	<meta property="og:type" content="article" />
	<meta property="og:url" id="og_url" content="https://www.sciencedaily.com/releases/2024/07/240710195323.htm" />
	<meta property="og:image" content="https://www.sciencedaily.com/images/scidaily-icon.png" />
	<meta property="og:description" id="og_description" content="CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy's molecular target improved response." />
	<meta property="og:site_name" content="ScienceDaily" />

	<link rel="canonical" href="https://www.sciencedaily.com/releases/2024/07/240710195323.htm" />
	<link rel="alternate" type="application/rss+xml" title="ScienceDaily: Latest Science News" href="https://www.sciencedaily.com/rss/" />

	<!-- Bootstrap core CSS -->
	<link href="/css/bootstrap.min.css" rel="stylesheet" />

	<!-- Font Awesome CSS -->
	<link href="/css/font-awesome.min.css" rel="stylesheet" />

	<!-- YAMM!3 CSS -->
	<link href="/css/yamm.css" rel="stylesheet" />
	
	<!-- Social Share Kit CSS -->
	<link href="/css/social-share-kit.css" rel="stylesheet" type="text/css" />

	<!-- Custom styles for this template -->
	<link href="/css/custom-202404121350.css" rel="stylesheet" />
	
<script type="text/javascript">
	/* Google Analytics TCF 2.0 support */
	window['gtag_enable_tcf_support'] = true;
</script>

<!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-GT6V1PPT8H"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());
  gtag('config', 'G-GT6V1PPT8H');
</script>

<script type="text/javascript" async="async" data-noptimize="1" data-cfasync="false" src="//scripts.pubnation.com/tags/31bd5f42-f769-4167-8846-a066e0e8ced7.js"></script>

</head>
<body>

<header>

	<a href="#main" class="skip">Skip to main content</a>

	<!-- Container -->
    <div class="container white">
	    
		<!-- Row -->
	    <div class="row header">
		    
		    <div class="col-sm-5 col-md-4 no-padding-right">
			    <div class="logo">
				    <a href="/" title="ScienceDaily"><img src="/images/sd-logo.png" height="43" width="260" alt="ScienceDaily" /></a>
				    <hr class="hr-logo" />
				    <div class="clearfix"></div>
				    <div class="motto">Your source for the latest research news</div>
			    </div>
		    </div>
		    
			<div class="col-sm-7 col-md-8 no-padding-left hidden-xs">
				<div class="sharing">
					<div id="controls" class="btn-group" role="group" aria-label="...">
						<a href="#" class="btn btn-default topbar hidden-xs" role="button" aria-disabled="true">Follow:</a>
						<a href="https://www.facebook.com/sciencedaily" class="btn btn-default" data-toggle="tooltip" data-placement="bottom" title="Facebook" aria-label="Facebook Page"><i class="fa fa-facebook fa-fw" role="presentation"><span class="display-none">Facebook</span></i></a>
						<a href="https://twitter.com/sciencedaily" class="btn btn-default" data-toggle="tooltip" data-placement="bottom" title="X/Twitter" aria-label="X/Twitter Page"><i class="fa fa-twitter fa-fw" role="presentation"><span class="display-none">X/Twitter</span></i></a>
						<a href="#" class="btn btn-default topbar hidden-xs" role="button" aria-disabled="true">Subscribe:</a>
						<a href="/newsfeeds.htm" class="btn btn-default hidden-tiny" data-toggle="tooltip" data-placement="bottom" title="RSS Feeds" aria-label="RSS Feeds"><i class="fa fa-rss fa-fw" role="presentation"><span class="display-none">RSS Feeds</span></i></a>
						<a href="https://sciencedaily.substack.com" class="btn btn-default" target="_blank" data-toggle="tooltip" data-placement="bottom" title="Newsletter" aria-label="Newsletter"><i class="fa fa-envelope-o fa-fw" role="presentation"><span style="display: none">Newsletter</span></i></a>
					</div>
				</div>

			</div>

		</div>
		
		<div id="callout">
<strong>New!</strong> Sign up for our free <strong><a href="https://sciencedaily.substack.com/#" target="_blank">email newsletter</a></strong>.</div>
		
	</div>
<!-- /container -->

</header>

    <div id="contents" class="container white">
	    
	<div class="row">

		<!-- Main -->
		<main id="main">
		<div class="col-sm-8 main less-padding-right hyphenate">
			
			<!-- Top Science News -->
			<div class="head no-print">
				<div class="pull-left head-left">Science News</div>
				<div class="pull-right head-right">from research organizations</div>
			</div>
			<div class="clearfix"></div>
			<hr class="head-rule no-print" />
			
			<h1 id="headline" class="headline">Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation</h1>
			
			
			<dl class="dl-horizontal dl-custom">
				<dt>Date:</dt>
				<dd id="date_posted">July 10, 2024</dd>
				<dt>Source:</dt>
				<dd id="source">Stanford Medicine</dd>
				<dt>Summary:</dt>
				<dd id="abstract">CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy's molecular target improved response.
</dd>
				<dt class="no-print">Share:</dt>
				<dd class="no-print">
					<div id="share_top">
						<div data-url="https://www.sciencedaily.com/releases/2024/07/240710195323.htm" class="ssk-sm ssk-group">
							<a href="#" class="ssk ssk-icon ssk-facebook" aria-label="Facebook"><span class="display-none">Facebook</span></a>
							<a href="#" class="ssk ssk-icon ssk-twitter" aria-label="Twitter"><span class="display-none">Twitter</span></a>
							<a href="#" class="ssk ssk-icon ssk-pinterest" aria-label="Pinterest"><span class="display-none">Pinterest</span></a>
							<a href="#" class="ssk ssk-icon ssk-linkedin" aria-label="LinkedIN"><span class="display-none">LinkedIN</span></a>
							<a href="#" class="ssk ssk-icon ssk-email" aria-label="Email"><span class="display-none">Email</span></a>
						</div>
					</div>
				</dd>
			</dl>
			
						<div class="mobile-top-rectangle">
				
						</div>
				
			<div class="row">
				
				<div class="col-md-8 col-md-push-4">
					
					<div class="fullstory">FULL STORY</div>
					<hr class="hr-fullstory" />

					<!-- /story_photo -->
					<div class="clearfix"></div>

					<div id="story_text" class="hyphenate underline">

						<p id="first" class="lead">CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear in about half of patients with large B-cell lymphoma who haven't experienced improvement with chemotherapy treatments.</p>

						<div id="text">
<p>But if this CAR-T treatment fails, or the cancer returns yet again -- as happens in approximately half of people -- the prognosis is dire. The median survival time after relapse is about six months.</p>
<p>Now, a phase 1 clinical trial at Stanford Medicine has found that a new CAR-T cell therapy that targets a different protein on the surface of the cancer cells significantly improved these patients' outcomes: Over half of 38 people enrolled in the trial -- 37 of whom had already relapsed from the original CAR-T therapy -- experienced a complete response of their cancers. More than half of all treated patients lived at least two years after treatment.</p>
<p>"On average, the patients enrolled in this trial had received four previous lines of therapy," said assistant professor of medicine and the trial's principal investigator Matthew Frank, MD, PhD. "These patients are out of likely curative options, and they are scared. Half of them will die within five to six months. But in this trial, we saw a very high rate of durable complete responses, meaning their cancers became undetectable."</p>
<p><strong>'Breakthrough therapy'</strong></p>
<p>The original CAR-T therapy, approved by the Food and Drug Administration in 2017, involves removing immune cells from the patient and inserting a gene to help the cells attack a protein called CD19 on the surface of the lymphoma cells. The new version of the therapy instead targets a molecule called CD22.</p>
<p>In September 2022, the FDA designated CD22-targeting CAR-T therapy for large B-cell lymphoma a Breakthrough Therapy, a move that is meant to speed the development and review of particularly promising drugs that may provide a substantial improvement over existing therapies for serious conditions.</p>

<div id="insertion_middle"></div>
<p>The study was devised and conducted entirely at Stanford Medicine.</p>
<p>"This trial was an example of what it means to take an idea from preclinical studies in animals all the way into the patient at an academic medical center," said David Miklos, MD, PhD, professor of medicine and chief of bone marrow transplantation and cellular therapy. "Remarkably, the FDA -- after reviewing our preliminary data -- contacted us to urge us to apply for breakthrough therapy designation, rather than waiting for us to approach them. This will help us significantly as we move into larger clinical trials."</p>
<p>A larger, phase 2 trial led by Frank is now ongoing at multiple sites around the country.</p>
<p>Miklos is the senior author of the study, which will be published July 9 in <em>The Lancet</em>. Frank; assistant professor of medicine John Baird, MD; and postdoctoral scholar Anne Kramer, MD, PhD, are the lead authors of the research.</p>
<p>CAR-T cell therapy was first approved by the FDA as a treatment for relapsed or treatment-resistant diffuse large B-cell lymphoma and for children and young adults under 25 with acute lymphoblastic leukemia.</p>
<p>Six CAR-T cell therapies are now approved for several types of lymphoma, multiple myeloma and acute lymphoblastic leukemia. Four of these therapies target CD19, which is found on the surface of healthy and cancerous B cells; two target another protein on the cells' surface called B cell maturation agent.</p>

<div id="insertion_bottom"></div>
<p>CD22 is another protein found on the surface of mature B cells, and researchers have been eying it for some time as a possible second target for CAR-T cell therapy. That's because, although CAR-T cell therapy targeting CD19 is typically successful, many patients relapse quickly as the cancer cells figure out how to reduce the amounts of CD19 on their surfaces or their engineered immune cells become exhausted from a prolonged attack.</p>
<p>Several trials have experimented with engineering CAR-T cells that recognize both CD19 and CD22 -- exploring whether a double volley of attack might eliminate cancer cells before they learn how to evade the treatment.</p>
<p>These efforts have met with mixed success. While more people with acute lymphoblastic leukemia responded to the double-targeted CAR-T therapy, the results for people with lymphoma were more tempered. In a trial conducted at Stanford Medicine, the therapy had some efficacy but was no more effective than targeting CD19 alone. Frank, Miklos and their colleagues wondered what would happen if only CD22 were targeted.</p>
<p><strong>A new target</strong></p>
<p>The researchers collected immune cells called T cells from 38 patients with large B-cell lymphoma whose cancers had started growing after previous therapies including chemotherapy. All but one of the patients had also progressed after CAR-T therapy targeting CD19; the cancer cells of the one remaining patient did not express CD19 on their surfaces.</p>
<p>The T cells were grown and genetically engineered to target CD22 in Stanford Medicine's Laboratory for Cell and Gene Medicine in partnership with the Center for Cancer Cell Therapy. They were then infused back into the patients from whom they were derived.</p>
<p>Of the 38 patients, 68% saw their cancers shrink, and 53% achieved a complete response, meaning their cancers were no longer detectable.</p>
<p>"This is not just a high response rate, but many of these remissions have been quite durable over a median of 30 months of follow-up," Frank said. "If this holds true in larger trials, it will surpass other therapeutic option we have for these patients." Additionally, most patients experienced minimal, manageable side effects.</p>
<p>The results of the trial are the first in a series of hurdles CD22-targeted CAR-T cell therapy will have to clear for it to be approved by the FDA for routine clinical use for those with intractable large B-cell lymphoma. According to Miklos, it also highlights the advantages of intertwining medicine and research.</p>
<p>"We conducted the preclinical studies at Stanford Medicine, translated the findings in our cell manufacturing and cancer cell therapy centers, and cared for the patients here," Miklos said. "This pipeline allows us to leverage our research and clinical findings in an iterative way. If something is not working, we can refocus and retool our approach to pivot quickly to new approaches to help our patients."</p>
<p>"It is rare for an academic medical center to attain a breakthrough designation," Frank noted. "It's humbling. Larger trials need to be completed, and FDA approval is not guaranteed, but this is a huge achievement for all the members of the team and a hopeful sign for patients and their caregivers."</p>
<p>Researchers from Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan and Cancer Center Amsterdam, who are currently working at Stanford, contributed to the work.</p>
<p>The study was funded by the National Institutes of Health (grants 2P01CA049605-29A1, 5P30CA124435 and K08CA248968), the Virginia and D.K. Ludwig Fund for Cancer Research, the Parker Institute for Cancer Immunotherapy, the European Hematology Association, the Lymph&amp;Co Foundation, and the Leukemia and Lymphoma Society.</p>
<p>Miklos has consulted for Kite Pharma-Gilead, Juno Therapeutics-Celgene, Novartis, Janssen and Pharmacyclics. Research support from Kite Pharma-Gilead, Allogene, CARGO Therapeutics, Pharmacyclics, Miltenyi Biotec and Adaptive Biotechnologies.</p>
<p>Frank has consulted for Kite Pharma-Gilead, Adaptative Biotechnologies and CARGO Therapeutics; he has also received research support from Kite-Pharma-Gilead, Allogene Therapeutics, Cargo Therapeutics and Adaptative Biotechnologies.</p>
<p>Study co-author Crystal Mackall, MD, the Earnest and Amelia Gallo Family Professor and professor of pediatrics and of medicine, is a founder of CARGO Therapeutics and holds equity in and consults for the company. CARGO holds the license for the CD22-directed CAR-T cell therapy.</p>
</div>

					</div>
<!-- /story_text -->

				</div>
<!-- /col-md-8 -->
				
				<div class="col-md-4 col-md-pull-8 less-padding-left no-print">
					
					<div class="row">

						<div class="col-xs-6 col-md-12">
							
							<ul class="nav topics">
								<li class="nav-header">
<a href="#">RELATED TOPICS</a>
									<ul id="related_topics" class="nav subnav">
										<li>
<a href="/news/health_medicine/">Health &amp; Medicine</a>
											<ul class="nav nav-condensed fa-ul">
												<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/news/health_medicine/lymphoma/" rel="tag">Lymphoma</a>
</li>
												<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/news/health_medicine/leukemia/" rel="tag">Leukemia</a>
</li>
												<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/news/health_medicine/diseases_and_conditions/" rel="tag">Diseases and Conditions</a>
</li>
												<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/news/health_medicine/personalized_medicine/" rel="tag">Personalized Medicine</a>
</li>
												<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/news/health_medicine/immune_system/" rel="tag">Immune System</a>
</li>
												<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/news/health_medicine/stem_cells/" rel="tag">Stem Cells</a>
</li>
												<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/news/health_medicine/cancer/" rel="tag">Cancer</a>
</li>
												<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/news/health_medicine/gene_therapy/" rel="tag">Gene Therapy</a>
</li>
											</ul>
										</li>
</ul>
								</li>
							</ul>
							
						</div>
						
						<div class="col-xs-6 col-md-12">

							<ul class="nav topics">
								<li class="nav-header">
<a href="#">RELATED TERMS</a>
									<ul id="related_terms" class="nav nav-condensed fa-ul">
										<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/terms/gene_therapy.htm">Gene therapy</a>
</li>
										<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/terms/massage.htm">Massage</a>
</li>
										<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/terms/maggot_therapy.htm">Maggot therapy</a>
</li>
										<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/terms/chinese_food_therapy.htm">Chinese food therapy</a>
</li>
										<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/terms/vector_(biology).htm">Vector (biology)</a>
</li>
										<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/terms/therapy_dog.htm">Therapy dog</a>
</li>
										<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/terms/occupational_therapy.htm">Occupational therapy</a>
</li>
										<li>
<i class="fa-li fa fa-angle-right" role="presentation"></i><a href="/terms/electroconvulsive_therapy.htm">Electroconvulsive therapy</a>
</li>
</ul>
								</li>
							</ul>
		
						</div>
<!-- /col-xs-6 -->

					</div>
<!-- /row -->

				</div>
<!-- /col-md-4 -->
				
			</div>
<!-- /row -->
			
			<div id="insertion_end"></div>
			
						<hr />

						<div id="story_source">								<p><strong>Story Source:</strong></p>
								<p><a href="https://med.stanford.edu/news/all-news/2024/07/cell-based-therapy-lymphoma-fda-breakthrough-designation.html" style="text-decoration: underline" rel="noopener noreferrer" target="_blank">Materials</a> provided by <a href="https://med.stanford.edu" rel="noopener noreferrer" target="_blank"><strong>Stanford Medicine</strong></a>. Original written by Krista Conger. <em>Note: Content may be edited for style and length.</em></p>
</div>
<!-- /story_source -->
				
						<hr />
						<!-- /related_multimedia -->
						<div id="journal_references"><p><strong>Journal Reference</strong>:</p>
<ol class="journal">
<li>Matthew J Frank, John H Baird, Anne Marijn Kramer, Hrishikesh K Srinagesh, Shabnum Patel, Annie Kathleen Brown, Jean S Oak, Sheren F Younes, Yasodha Natkunam, Mark P Hamilton, Yi-Jiun Su, Neha Agarwal, Harshini Chinnasamy, Emily Egeler, Sharon Mavroukakis, Steven A Feldman, Bita Sahaf, Crystal L Mackall, Lori Muffly, David B Miklos, Dorota Danuta Klysz, Nikolaos Gkitsas-Long, Juliana Bacigalupi, Maria Iglesias, Emma Crawford, Linnea Nichols, Kristen Cunanan, John Tamaresis, Jay Y. Spiegel, Zachary Ehlinger, Adam Kuo, Warren D. Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen Kai Weng, Sushma Bharadwaj, Saurabh Dahiya, Melody Smith, Liora M. Schultz, Sneha Ramakrishna, Kara L. Davis, Ramya Tunuguntla. <strong>CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study</strong>. <em>The Lancet</em>, 2024; DOI: <a href="http://dx.doi.org/10.1016/S0140-6736(24)00746-3" style="text-decoration: underline" rel="noopener noreferrer" target="_blank">10.1016/S0140-6736(24)00746-3</a>
</li>
</ol>
<hr />
</div>
<!-- /journal_references -->

						<div id="citations">

							<div role="tabpanel" class="right-tabs clearfix">

								<p class="pull-left"><strong>Cite This Page</strong>:</p>

								<!-- Nav tabs -->
								<ul class="nav nav-tabs" role="tablist">
									<li role="presentation" class="active"><a href="#citation_mla" aria-controls="citation_mla" role="tab" data-toggle="tab">MLA</a></li>
									<li role="presentation"><a href="#citation_apa" aria-controls="citation_apa" role="tab" data-toggle="tab">APA</a></li>
									<li role="presentation"><a href="#citation_chicago" aria-controls="citation_chicago" role="tab" data-toggle="tab">Chicago</a></li>
								</ul>
								
								<!-- Tab panes -->
								<div class="tab-content tab-citations">
									<div role="tabpanel" class="tab-pane active" id="citation_mla">Stanford Medicine. "Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation." ScienceDaily. ScienceDaily, 10 July 2024. &lt;www.sciencedaily.com<wbr></wbr>/<wbr></wbr>releases<wbr></wbr>/<wbr></wbr>2024<wbr></wbr>/<wbr></wbr>07<wbr></wbr>/<wbr></wbr>240710195323.htm&gt;.</div>
									<div role="tabpanel" class="tab-pane" id="citation_apa">Stanford Medicine. (2024, July 10). Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation. <em>ScienceDaily</em>. Retrieved July 10, 2024 from www.sciencedaily.com<wbr></wbr>/<wbr></wbr>releases<wbr></wbr>/<wbr></wbr>2024<wbr></wbr>/<wbr></wbr>07<wbr></wbr>/<wbr></wbr>240710195323.htm</div>
									<div role="tabpanel" class="tab-pane" id="citation_chicago">Stanford Medicine. "Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation." ScienceDaily. www.sciencedaily.com<wbr></wbr>/<wbr></wbr>releases<wbr></wbr>/<wbr></wbr>2024<wbr></wbr>/<wbr></wbr>07<wbr></wbr>/<wbr></wbr>240710195323.htm (accessed July 10, 2024).</div>
								</div>

							</div>
			
							<div class="clearfix"></div>

						</div>
<!-- end citations -->

						<div class="clearfix"></div>

						<br />

			<div class="head">
	            <h2 id="exploremore_heading" class="pull-left head-left">Explore More</h2>
	            <div class="pull-right head-right">from ScienceDaily</div>
	        </div>
	        <div class="clearfix"></div>
	        <hr class="head-rule" />
	
			
						
			<div class="fullstory">RELATED STORIES</div>
			<hr class="hr-fullstory" />
	
			<div id="related_releases">					<div class="related-headline clearfix"><a href="/releases/2023/01/230109112811.htm">New Biomarker for Early Prediction of Response to CAR-T Cell Therapy</a></div>
					<div class="related-summary">
<span class="story-date">Jan. 9, 2023 &#151;</span> A research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for lymphoma treatment. The ... </div>					<div class="related-headline clearfix"><a href="/releases/2022/05/220512164045.htm">Researchers Seek to Improve Success of Chimeric Antigen Receptor-T Cell Therapy in Non-Hodgkin Lymphoma</a></div>
					<div class="related-summary">
<span class="story-date">May 12, 2022 &#151;</span> A study investigates the reasons for decreasing remission rates for patients with non-Hodgkin lymphoma treated with chimeric antigen receptor-T cell therapy (CAR-T cell ... </div>					<div class="related-headline clearfix"><a href="/releases/2020/09/200902152138.htm">Scientists Use Two Powerful Immunotherapies to Eradicate Solid Tumors</a></div>
					<div class="related-summary">
<span class="story-date">Sep. 2, 2020 &#151;</span> Scientists have combined two potent immunotherapies -- an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy -- to target and eradicate solid tumors that are otherwise difficult to ... </div>					<div class="related-headline clearfix"><a href="/releases/2019/09/190917160122.htm">Radiation May Lower Potential for Side Effects of CAR T Therapy in Non-Hodgkin's Lymphoma</a></div>
					<div class="related-summary">
<span class="story-date">Sep. 17, 2019 &#151;</span> Treating non-Hodgkin's lymphoma (NHL) patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side ... </div>
</div>
	
		</div>
		</main>
		<!-- /Main -->

		<!-- Sidebar -->
		<div class="col-sm-4 less-padding-left sidebar no-print">
			<div class="pull-right btn-group btn-group-sm tools-top hidden-tiny hidden-xs" role="group" aria-label="...">
				<a href="#" class="btn btn-default print black" role="button"><i class="fa fa-print" role="presentation"></i> &nbsp; <span class="hidden-sm">Print</span></a>
				<a href="#" class="btn btn-default email black" role="button"><i class="fa fa-envelope" role="presentation"></i> &nbsp; <span class="hidden-sm">Email</span></a>
				<a href="#" class="btn btn-default black" data-toggle="modal" data-target="#shareModal" role="button"><i class="fa fa-share" role="presentation"></i> &nbsp; <span class="hidden-sm">Share</span></a>
			</div>
			<div class="clearfix"></div>
			<hr class="hr-tools-top" />
			
			<div class="subhead">
				<h2 id="breaking_heading" class="pull-left subhead-left"><a href="/breaking/" class="breaking-head">Breaking</a></h2>
				<div class="pull-right subhead-right">this hour</div>
			</div>
			<div class="clearfix"></div>
			<hr class="head-rule" />
			
			<ul id="justin_headlines" class="list-unstyled breaking-list">
	
	<li><a href="/releases/2024/07/240710195329.htm">Prime Editing Corrects Cystic Fibrosis Mutation?</a></li>
	

	
	<li><a href="/releases/2024/07/240710135244.htm">Artificial 'Muscles' for Safer, Softer Robots</a></li>
	

	
	<li><a href="/releases/2024/07/240710195436.htm">New Species of Extinct Crocodile Relative</a></li>
	

	
	<li><a href="/releases/2024/07/240710130824.htm">Cause of Lupus and Possible Way to Reverse It</a></li>
	

	
	<li><a href="/releases/2024/07/240710130921.htm">Most Complete Dinosaur Found in UK in a Century</a></li>
	

	
	<li><a href="/releases/2024/07/240710130900.htm">The Origins of Dark Comets</a></li>
	

	
	<li><a href="/releases/2024/07/240710130836.htm">Gulf Stream Weakening With Climate Change?</a></li>
	

	
	<li><a href="/releases/2024/07/240710130826.htm">Treating Stroke-Related Brain Injury</a></li>
	

	
	<li><a href="/releases/2024/07/240710130820.htm">Boost for Battle Against Harmful Bacteria</a></li>
	

	
	<li><a href="/releases/2024/07/240710130803.htm">'Missing Middle' Black-Hole in Omega Centauri</a></li>
	
</ul>
			
			<div class="subhead extra-top-margin">
				<h2 id="most_popular_heading" class="pull-left subhead-left">Trending Topics</h2>
				<div class="pull-right subhead-right">this week</div>
			</div>
			<div class="clearfix"></div>
			<hr class="head-rule" />
			
			<div id="most_popular_section1_head" class="side-subhead"><a href="/news/health_medicine/" class="gray">HEALTH &amp; MEDICINE</a>
</div>
			<div id="most_popular_section1">
	<div class="sidebar-headline clearfix"><a href="/news/health_medicine/pain_control/">Pain Control</a></div>
	<div class="sidebar-headline clearfix"><a href="/news/health_medicine/neuropathy/">Neuropathy</a></div>
	<div class="sidebar-headline clearfix"><a href="/news/health_medicine/joint_pain/">Joint Pain</a></div>
</div>

			<div id="most_popular_section2_head" class="side-subhead"><a href="/news/mind_brain/" class="gray">MIND &amp; BRAIN</a>
</div>
			<div id="most_popular_section2">
	<div class="sidebar-headline clearfix"><a href="/news/mind_brain/literacy/">Literacy</a></div>
	<div class="sidebar-headline clearfix"><a href="/news/mind_brain/creativity/">Creativity</a></div>
	<div class="sidebar-headline clearfix"><a href="/news/mind_brain/brain_injury/">Brain Injury</a></div>
</div>
			
			<div id="most_popular_section3_head" class="side-subhead"><a href="/news/living_well/" class="gray">LIVING &amp; WELL</a>
</div>
			<div id="most_popular_section3">
	<div class="sidebar-headline clearfix"><a href="/news/health_medicine/caregiving/">Elder Care</a></div>
	<div class="sidebar-headline clearfix"><a href="/news/health_medicine/nutrition/">Nutrition</a></div>
	<div class="sidebar-headline clearfix"><a href="/news/health_medicine/staying_healthy/">Staying Healthy</a></div>
</div>
			
			<div class="halfpage double-extra-top-margin">

			</div>

			<div class="subhead extra-top-margin">
				<h2 id="strange_offbeat_heading" class="pull-left subhead-left">Strange &amp; Offbeat</h2>
				<div class="pull-right subhead-right">&nbsp;</div>
			</div>
			<div class="clearfix"></div>
			<hr class="head-rule" />
			
			<div id="strange_offbeat_section1_head" class="side-subhead"><a href="/news/strange_offbeat/health_medicine/" class="gray">HEALTH &amp; MEDICINE</a>
</div>
			<div id="strange_offbeat_section1">
	<div class="sidebar-headline clearfix"><a href="/releases/2024/07/240702200410.htm">Clever Clothes! Seams in Clothing Capture Body Movement</a></div>
	<div class="sidebar-headline clearfix"><a href="/releases/2024/07/240702161542.htm">Two New Species of Psilocybe Mushrooms Discovered in Southern Africa</a></div>
	<div class="sidebar-headline clearfix"><a href="/releases/2024/07/240702135411.htm">Doctors Could Soon Use Facial Temperature for Early Diagnosis of Metabolic Diseases</a></div>
</div>

			<div id="strange_offbeat_section2_head" class="side-subhead"><a href="/news/strange_offbeat/mind_brain/" class="gray">MIND &amp; BRAIN</a>
</div>
			<div id="strange_offbeat_section2">
	<div class="sidebar-headline clearfix"><a href="/releases/2024/07/240701162221.htm">New and Improved Camera Inspired by the Human Eye</a></div>
	<div class="sidebar-headline clearfix"><a href="/releases/2024/06/240625205646.htm">Next Platform for Brain-Inspired Computing</a></div>
	<div class="sidebar-headline clearfix"><a href="/releases/2024/06/240624125640.htm">Meet CARMEN, a Robot That Helps People With Mild Cognitive Impairment</a></div>
</div>
			
			<div id="strange_offbeat_section3_head" class="side-subhead"><a href="/news/strange_offbeat/living_well/" class="gray">LIVING &amp; WELL</a>
</div>
			<div id="strange_offbeat_section3">
	<div class="sidebar-headline clearfix"><a href="/releases/2024/06/240611130440.htm">Research on the Visual Rabbit Illusion Takes a Leap Forward</a></div>
	<div class="sidebar-headline clearfix"><a href="/releases/2024/06/240605162522.htm">Babies Use 'Helpless' Infant Period to Learn Powerful Foundation Models, Just Like ChatGPT</a></div>
	<div class="sidebar-headline clearfix"><a href="/releases/2024/06/240604132017.htm">Unraveling the Physics of Knitting</a></div>
</div>
			
		</div>
		<!-- /Sidebar -->

	</div>
	<!-- /Row -->

	<br />

	</div> <!-- /Container -->

<div id="navwrapper">
<div id="topnav">
	<!-- Static navbar -->
	<nav class="navbar yamm navbar-default navbar-static navbar-custom"><div class="container">
		<div class="navbar-header">
		  <button type="button" class="navbar-toggle collapsed menu" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar">
			<span class="sr-only">Toggle navigation</span>
			<span>Menu &nbsp;<i class="fa fa-bars" role="presentation"></i></span>
		  </button>
		  <a class="navbar-brand visible-xs" href="#"><span class="icon-s">S<span class="icon-d">D</span></span></a>
		  <ul class="nav navbar-nav hidden-xs">
<li class="dropdown">
			  <a href="#" class="navbar-brand dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true"><span class="icon-s">S<span class="icon-d">D</span></span></a>
			  <ul class="dropdown-menu brand" role="menu">
<li><a href="/" role="menuitem">Home Page</a></li>
				<li class="divider">
				</li>
<li><a href="/news/top/science/" role="menuitem">Top Science News</a></li>
				<li class="divider">
				</li>
<li><a href="/news/" role="menuitem">Latest News</a></li>
			  </ul>
</li>
		  </ul>
</div>
		<div id="navbar" class="navbar-collapse collapse">
		  <ul class="nav navbar-nav">
<li class="dropdown visible-xs">
			  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true">Home <span class="caret" role="presentation"></span></a>
			  <ul class="dropdown-menu" role="menu">
<li><a href="/" role="menuitem">Home Page</a></li>
				<li class="divider">
				</li>
<li><a href="/news/top/science/" role="menuitem">Top Science News</a></li>
				<li class="divider">
				</li>
<li><a href="/news/" role="menuitem">Latest News</a></li>
			  </ul>
<!-- /dropdown-menu -->
</li>
<!-- /dropdown -->
			<li class="dropdown">
			  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true">Health <span class="caret" role="presentation"></span></a>
			  <ul class="dropdown-menu dropdown-menu-left" role="menu">
<li class="menu-item">
					  <div class="yamm-content hyphenate">
						  <div>View all the latest <strong><a href="/news/top/health/">top news</a></strong> in the health sciences, <span class="hidden-xs hidden-sm" role="presentation"><br /></span>or browse the topics below:</div>
						  <div class="row">
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/health_medicine/">Health &amp; Medicine</a></div>
									<ul class="list-unstyled menu-topics">
<li><a href="/news/health_medicine/allergy/" role="menuitem">Allergy</a></li>
										<li><a href="/news/health_medicine/cancer/" role="menuitem">Cancer</a></li>
										<li><a href="/news/health_medicine/cold_and_flu/" role="menuitem">Cold and Flu</a></li>
										<li><a href="/news/health_medicine/diabetes/" role="menuitem">Diabetes</a></li>
									
										<li><a href="/news/health_medicine/heart_disease/" role="menuitem">Heart Disease</a></li>
									
										<li><a href="/news/health_medicine/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/mind_brain/" role="menuitem">Mind &amp; Brain</a></div>
									<ul class="list-unstyled menu-topics">
<li><a href="/news/mind_brain/add_and_adhd/" role="menuitem">ADD and ADHD</a></li>
									
										<li><a href="/news/mind_brain/alzheimer's/" role="menuitem">Alzheimer's</a></li>
									
										<li><a href="/news/mind_brain/headaches/" role="menuitem">Headaches</a></li>
										<li><a href="/news/mind_brain/intelligence/" role="menuitem">Intelligence</a></li>
									
										<li><a href="/news/mind_brain/psychology/" role="menuitem">Psychology</a></li>
									
										<li><a href="/news/mind_brain/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/living_well/" role="menuitem">Living Well</a></div>
									<ul class="list-unstyled menu-topics">
<li><a href="/news/mind_brain/parenting/" role="menuitem">Parenting</a></li>
										<li><a href="/news/mind_brain/child_development/" role="menuitem">Child Development</a></li>
										<li><a href="/news/mind_brain/stress/" role="menuitem">Stress</a></li>
										<li><a href="/news/health_medicine/nutrition/" role="menuitem">Nutrition</a></li>
										<li><a href="/news/health_medicine/fitness/" role="menuitem">Fitness</a></li>
					
										<li><a href="/news/living_well/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
						  </div>
<!-- /row -->
					  </div>
<!-- /yamm-content -->
				  </li>
<!-- /menu-item -->
			  </ul>
<!-- /dropdown-menu -->
</li>
<!-- /dropdown -->
				  
			<li class="dropdown">
			  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true">Tech <span class="caret" role="presentation"></span></a>
			  <ul class="dropdown-menu dropdown-menu-left" role="menu">
<li class="menu-item">
					  <div class="yamm-content hyphenate">
						  <div>View all the latest <strong><a href="/news/top/technology/">top news</a></strong> in the physical sciences &amp; technology, <span class="hidden-xs hidden-sm" role="presentation"><br /></span>or browse the topics below:</div>
						  <div class="row">
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/matter_energy/" role="menuitem">Matter &amp; Energy</a></div>
									<ul class="list-unstyled menu-topics">
										<li><a href="/news/matter_energy/chemistry/" role="menuitem">Chemistry</a></li>
									
										<li><a href="/news/matter_energy/fossil_fuels/" role="menuitem">Fossil Fuels</a></li>
									
										<li><a href="/news/matter_energy/nanotechnology/" role="menuitem">Nanotechnology</a></li>
										<li><a href="/news/matter_energy/physics/" role="menuitem">Physics</a></li>
									
										<li><a href="/news/matter_energy/solar_energy/" role="menuitem">Solar Energy</a></li>
										<li><a href="/news/matter_energy/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/space_time/" role="menuitem">Space &amp; Time</a></div>
									<ul class="list-unstyled menu-topics">
									
										<li><a href="/news/space_time/black_holes/" role="menuitem">Black Holes</a></li>
										<li><a href="/news/space_time/dark_matter/" role="menuitem">Dark Matter</a></li>
									
										<li><a href="/news/space_time/extrasolar_planets/" role="menuitem">Extrasolar Planets</a></li>
					
										<li><a href="/news/space_time/solar_system/" role="menuitem">Solar System</a></li>
										<li><a href="/news/space_time/space_telescopes/" role="menuitem">Space Telescopes</a></li>
									
										<li><a href="/news/space_time/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/computers_math/" role="menuitem">Computers &amp; Math</a></div>
									<ul class="list-unstyled menu-topics">
<li><a href="/news/computers_math/artificial_intelligence/" role="menuitem">Artificial Intelligence</a></li>
										<li><a href="/news/computers_math/mathematics/" role="menuitem">Mathematics</a></li>
										<li><a href="/news/computers_math/quantum_computers/" role="menuitem">Quantum Computers</a></li>
									
										<li><a href="/news/computers_math/robotics/" role="menuitem">Robotics</a></li>
										<li><a href="/news/computers_math/virtual_reality/" role="menuitem">Virtual Reality</a></li>
									
										<li><a href="/news/computers_math/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
						  </div>
<!-- /row -->
					  </div>
<!-- /yamm-content -->
				  </li>
<!-- /menu-item -->
			  </ul>
<!-- /dropdown-menu -->
</li>
<!-- /dropdown -->
			<li class="dropdown">
			  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true">Enviro <span class="caret" role="presentation"></span></a>
			  <ul class="dropdown-menu dropdown-menu-left" role="menu">
<li class="menu-item">
					  <div class="yamm-content hyphenate">
						  <div>View all the latest <strong><a href="/news/top/environment/">top news</a></strong> in the environmental sciences, <span class="hidden-xs hidden-sm" role="presentation"><br /></span>or browse the topics below:</div>
						  <div class="row">
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/plants_animals/" role="menuitem">Plants &amp; Animals</a></div>
									<ul class="list-unstyled menu-topics">
<li><a href="/news/plants_animals/agriculture_and_food/" role="menuitem">Agriculture and Food</a></li>
									
										<li><a href="/news/plants_animals/biology/" role="menuitem">Biology</a></li>
										<li><a href="/news/plants_animals/biotechnology/" role="menuitem">Biotechnology</a></li>
									
									
										<li><a href="/news/plants_animals/extinction/" role="menuitem">Extinction</a></li>
										<li><a href="/news/plants_animals/microbes_and_more/" role="menuitem">Microbes and More</a></li>
									
										<li><a href="/news/plants_animals/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/earth_climate/" role="menuitem">Earth &amp; Climate</a></div>
									<ul class="list-unstyled menu-topics">
<li><a href="/news/earth_climate/climate/" role="menuitem">Climate</a></li>
									
										<li><a href="/news/earth_climate/earthquakes/" role="menuitem">Earthquakes</a></li>
									
										<li><a href="/news/earth_climate/geology/" role="menuitem">Geology</a></li>
										<li><a href="/news/earth_climate/global_warming/" role="menuitem">Global Warming</a></li>
										<li><a href="/news/earth_climate/pollution/" role="menuitem">Pollution</a></li>
									
										<li><a href="/news/earth_climate/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/fossils_ruins/" role="menuitem">Fossils &amp; Ruins</a></div>
									<ul class="list-unstyled menu-topics">
										<li><a href="/news/fossils_ruins/anthropology/" role="menuitem">Anthropology</a></li>
									
										<li><a href="/news/fossils_ruins/archaeology/" role="menuitem">Archaeology</a></li>
										<li><a href="/news/fossils_ruins/dinosaurs/" role="menuitem">Dinosaurs</a></li>
										<li><a href="/news/fossils_ruins/evolution/" role="menuitem">Evolution</a></li>
										<li><a href="/news/fossils_ruins/paleontology/" role="menuitem">Paleontology</a></li>
									
										<li><a href="/news/fossils_ruins/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
						  </div>
<!-- /row -->
					  </div>
<!-- /yamm-content -->
				  </li>
<!-- /menu-item -->
			  </ul>
<!-- /dropdown-menu -->
</li>
<!-- /dropdown -->
			<li class="dropdown">
			  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true">Society <span class="caret" role="presentation"></span></a>
			  <ul class="dropdown-menu dropdown-menu-left" role="menu">
<li class="menu-item">
					  <div class="yamm-content hyphenate">
						  <div>View all the latest <strong><a href="/news/top/society/">top news</a></strong> in the social sciences &amp; education, <span class="hidden-xs hidden-sm" role="presentation"><br /></span>or browse the topics below:</div>
						  <div class="row">
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/science_society/" role="menuitem">Science &amp; Society</a></div>
									<ul class="list-unstyled menu-topics">
<li><a href="/news/science_society/arts_and_culture/" role="menuitem">Arts &amp; Culture</a></li>
										<li><a href="/news/science_society/economics/" role="menuitem">Economics</a></li>
										<li><a href="/news/science_society/privacy_issues/" role="menuitem">Privacy Issues</a></li>
										<li><a href="/news/science_society/public_health/" role="menuitem">Public Health</a></li>
										<li><a href="/news/science_society/sports/" role="menuitem">Sports</a></li>
									
										<li><a href="/news/science_society/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/business_industry/" role="menuitem">Business &amp; Industry</a></div>
									<ul class="list-unstyled menu-topics">
										<li><a href="/news/computers_math/computers_and_internet/" role="menuitem">Computers &amp; Internet</a></li>
										<li><a href="/news/matter_energy/energy_and_resources/" role="menuitem">Energy &amp; Resources</a></li>
										<li><a href="/news/matter_energy/engineering/" role="menuitem">Engineering</a></li>
										<li><a href="/news/matter_energy/medical_technology/" role="menuitem">Medical Technology</a></li>
										<li><a href="/news/matter_energy/automotive_and_transportation/" role="menuitem">Transportation</a></li>
										
										<li><a href="/news/business_industry/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
							  <div class="col-xs-4">
								  <div class="menu-section"><a href="/news/education_learning/" role="menuitem">Education &amp; Learning</a></div>
									<ul class="list-unstyled menu-topics">
										<li><a href="/news/mind_brain/creativity/" role="menuitem">Creativity</a></li>
										<li><a href="/news/mind_brain/educational_psychology/" role="menuitem">Educational Psychology</a></li>
										<li><a href="/news/mind_brain/infant_and_preschool_learning/" role="menuitem">Infant &amp; Preschool</a></li>
										<li><a href="/news/mind_brain/learning_disorders/" role="menuitem">Learning Disorders</a></li>
										<li><a href="/news/science_society/stem_education/" role="menuitem">STEM Education</a></li>
										
										<li><a href="/news/education_learning/" role="menuitem">... <em>more topics</em></a></li>
									</ul>
<!-- /menu-topics -->
</div>
<!-- /col-xs-4 -->
						  </div>
<!-- /row -->
					  </div>
<!-- /yamm-content -->
				  </li>
<!-- /menu-item -->
			  </ul>
<!-- /dropdown-menu -->
</li>
<!-- /dropdown -->
			<li class="dropdown">
			  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true">Quirky <span class="caret" role="presentation"></span></a>
			  <ul class="dropdown-menu" role="menu">
				  <li><a href="/news/strange_offbeat/" role="menuitem">Top News</a></li>
				<li class="divider">
				</li>
<li><a href="/news/strange_offbeat/human_quirks/" role="menuitem">Human Quirks</a></li>
				<li><a href="/news/strange_offbeat/odd_creatures/" role="menuitem">Odd Creatures</a></li>
				<li><a href="/news/strange_offbeat/bizarre_things/" role="menuitem">Bizarre Things</a></li>
				<li><a href="/news/strange_offbeat/weird_world/" role="menuitem">Weird World</a></li>
			  </ul>
<!-- /dropdown-menu -->
</li>
<!-- /dropdown -->
		  </ul>
<form action="/search/" method="get" class="navbar-form navbar-right" role="search">
			  <div class="form-group search">
				  <div class="input-group">
					  <label id="keywordlabel" for="keyword" class="display-none">Keyword:</label><input type="text" id="keyword" name="keyword" aria-labelledby="keywordlabel" title="Enter keyword to search" class="form-control hidden-xs" placeholder="Search" /><span class="input-group-btn"><button class="btn btn-default" type="submit" aria-label="search"><i class="fa fa-search" role="presentation"><span class="display-none">Search</span></i></button></span>
</div>
			  </div>
		  </form>

		</div>
<!--/.nav-collapse -->
	  </div>
	</nav>
</div>
</div>
<!-- /navwrapper -->

<footer>
	
	<div class="container light-gray">

		<div class="row footer-links">
			<div class="col-sm-12 col-md-4">
				<div class="footer-head">Free Subscriptions</div>
				<hr class="footer-rule" />
				<p>Stay informed with ScienceDaily's free email newsletter, updated daily and weekly. Or view our many newsfeeds in your RSS reader:</p>
				<ul class="list-unstyled footer-list">
					<li>
<i class="fa fa-envelope fa-fw" role="presentation"></i> <a href="https://sciencedaily.substack.com">Email Newsletter</a>
</li>
					<li>
<i class="fa fa-rss fa-fw" role="presentation"></i> <a href="/newsfeeds.htm">RSS Feeds</a>
</li>
				</ul>
			</div>
			<div class="col-sm-12 col-md-4">
				<div class="footer-head">Follow Us</div>
				<hr class="footer-rule" />
				<p>Keep up to date with the latest news from ScienceDaily via social networks:</p>
				<ul class="list-unstyled footer-list">
					<li>
<i class="fa fa-facebook fa-fw" role="presentation"></i> <a href="https://www.facebook.com/sciencedaily">Facebook</a>
</li>
					<li>
<i class="fa fa-twitter fa-fw" role="presentation"></i> <a href="https://twitter.com/sciencedaily">X / Twitter</a>
</li>
				</ul>
			</div>
			<div class="col-sm-12 col-md-4">
				<div class="footer-head">Have Feedback?</div>
				<hr class="footer-rule" />
				<p>Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?</p>
				<ul class="list-unstyled footer-list">
					<li>
<i class="fa fa-comment fa-fw" role="presentation"></i> <a href="#" class="feedback" role="button">Leave Feedback</a>
</li>
					<li>
<i class="fa fa-phone fa-fw" role="presentation"></i> <a href="/contact.htm">Contact Us</a>
</li>
				</ul>
			</div>
		</div>

	</div>

	<div class="container dark-gray">
		<div class="bottom-links">
<a href="/about.htm">About This Site</a>  &nbsp;|&nbsp;  <a href="/staff.htm">Staff</a>  &nbsp;|&nbsp;  <a href="/contribute.htm">Contribute</a>  &nbsp;|&nbsp;  <a href="/advertise.htm">Advertise</a>  &nbsp;|&nbsp;  <a href="/privacy.htm">Privacy Policy</a>  &nbsp;|&nbsp; <a href="/editorial.htm">Editorial Policy</a> &nbsp;|&nbsp;  <a href="/terms.htm">Terms of Use</a>
		</div>
		<div id="bottom_text">
<a href="/copyright.htm">Copyright 1995-2024 ScienceDaily</a> or by other parties, where indicated. All rights controlled by their respective owners. Content on this website is for information only. It is not intended to provide medical or other professional advice. Views expressed here do not necessarily reflect those of ScienceDaily, contributors or partners. Financial support for ScienceDaily comes from advertisements and referral programs.</div>
	</div>
	
</footer>

	<!-- Bootstrap core JavaScript
	================================================== -->
	<!-- Placed at the end of the document so the pages load faster -->
    <script src="/js/jquery-3.6.0.min.js"></script>
    <script src="/js/bootstrap-3.4.1.min.js"></script>
	
	<script src="/js/jQuery.print.js"></script>

	<script src="/js/social-share-kit.min.js"></script>

	<script src="/js/custom-202307301940.js"></script>
		
  </body>
</html>
<!-- Page successfully generated: July 10, 2024 10:32:02 pm -->
